Retour aux projets

26019.2 PFLS-LS

Novel cell-based immunization technology and functional validation of resulting antibodies

Résumé

Novel cell-based immunization technology and functional validation of resulting antibodies

Textes supplémentaires

Abstract

Development of a novel immunization method in rabbits that improves the generation of antibodies against the native form of human proteins e.g. cell surface receptors. Subsequent validation of the method through functional characterisation of candidate therapeutic antibodies in vitro and in vivo.

Participants

Christoph Esslinger

Wirtschaftspartner

christoph.esslinger@memo-therapeutics.com

Memo Therapeutics AG c/o D-BSSE / ETH Zürich CHE-428.742.263 Christoph Esslinger Otto-Stern-Weg 7 8093 Zürich ZH CH

Jack Rohrer

Kontaktperson

jack.rohrer@zhaw.ch

ZHAW Jack Rohrer Einsiedlerstrasse 31a 8820 Wädenswil ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2017-11-30
Date de fin
2021-07-31
Coûts totaux approuvés
CHF 872906.71
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%